Literature DB >> 17707343

Rapamycin regulates the phosphorylation of rictor.

Argun Akcakanat1, Gopal Singh, Mien-Chie Hung, Funda Meric-Bernstam.   

Abstract

The mammalian target of rapamycin (mTOR) is a central regulator of cell growth. mTOR exists in two functional complexes, mTORC1 and mTORC2. mTORC1 is rapamycin-sensitive, and results in phosphorylation of 4E-BP1 and S6K1. mTORC2 is proposed to regulate Akt Ser473 phosphorylation and be rapamycin-insensitive. mTORC2 consists of mTOR, mLST8, sin1, Protor/PRR5, and the rapamycin insensitive companion of mTOR (rictor). Here, we show that rapamycin regulates the phosphorylation of rictor. Rapamycin-mediated rictor dephosphorylation is time and concentration dependent, and occurs at physiologically relevant rapamycin concentrations. siRNA knockdown of mTOR also leads to rictor dephosphorylation, suggesting that rictor phosphorylation is mediated by mTOR or one of its downstream targets. Rictor phosphorylation induced by serum, insulin and insulin-like growth factor is blocked by rapamycin. Rictor dephosphorylation is not associated with dephosphorylation of Akt Ser473. Further work is needed to better characterize the mechanism of rictor regulation and its role in rapamycin-mediated growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707343      PMCID: PMC2040311          DOI: 10.1016/j.bbrc.2007.07.151

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells.

Authors:  Wallace H Mondesire; Weiguo Jian; Haixia Zhang; Joe Ensor; Mien-Chie Hung; Gordon B Mills; Funda Meric-Bernstam
Journal:  Clin Cancer Res       Date:  2004-10-15       Impact factor: 12.531

2.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

3.  mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes.

Authors:  Richard C Hresko; Mike Mueckler
Journal:  J Biol Chem       Date:  2005-10-11       Impact factor: 5.157

4.  Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.

Authors:  Yijiang Shi; Huajun Yan; Patrick Frost; Joseph Gera; Alan Lichtenstein
Journal:  Mol Cancer Ther       Date:  2005-10       Impact factor: 6.261

5.  Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.

Authors:  Jinjiang Dong; Junying Peng; Haixia Zhang; Wallace H Mondesire; Weiguo Jian; Gordon B Mills; Mien-Chie Hung; Funda Meric-Bernstam
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

6.  Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Authors:  D D Sarbassov; Siraj M Ali; Do-Hyung Kim; David A Guertin; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

7.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Authors:  Estela Jacinto; Robbie Loewith; Anja Schmidt; Shuo Lin; Markus A Rüegg; Alan Hall; Michael N Hall
Journal:  Nat Cell Biol       Date:  2004-10-03       Impact factor: 28.824

8.  Determinants of rapamycin sensitivity in breast cancer cells.

Authors:  Woo-Chul Noh; Wallace H Mondesire; Junying Peng; Weiguo Jian; Haixia Zhang; JinJiang Dong; Gordon B Mills; Mien-Chie Hung; Funda Meric-Bernstam
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

9.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

10.  mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.

Authors:  Kathryn E O'Reilly; Fredi Rojo; Qing-Bai She; David Solit; Gordon B Mills; Debra Smith; Heidi Lane; Francesco Hofmann; Daniel J Hicklin; Dale L Ludwig; Jose Baselga; Neal Rosen
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

View more
  29 in total

1.  Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.

Authors:  Delphine Boulbes; Chien-Hung Chen; Tattym Shaikenov; Nitin K Agarwal; Timothy R Peterson; Terri A Addona; Hasmik Keshishian; Steven A Carr; Mark A Magnuson; David M Sabatini; Dos D Sarbassov
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

2.  Insights into the PI3-K-PKB-mTOR signalling pathway from small molecules.

Authors:  Richard M Gunn; Helen C Hailes
Journal:  J Chem Biol       Date:  2008-07-15

3.  Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.

Authors:  Deqiang Zhang; Xin Tong; Blake Arthurs; Anirvan Guha; Liangyou Rui; Avani Kamath; Ken Inoki; Lei Yin
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.

Authors:  Funda Meric-Bernstam; Argun Akcakanat; Huiqin Chen; Kim-Anh Do; Takafumi Sangai; Farrell Adkins; Ana Maria Gonzalez-Angulo; Asif Rashid; Katherine Crosby; Mei Dong; Alexandria T Phan; Robert A Wolff; Sanjay Gupta; Gordon B Mills; James Yao
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

Review 5.  mTOR complex 2 signaling and functions.

Authors:  Won Jun Oh; Estela Jacinto
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

Review 6.  Mammalian TOR signaling to the AGC kinases.

Authors:  Bing Su; Estela Jacinto
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-10       Impact factor: 8.250

7.  mTOR-rictor is the Ser473 kinase for AKT1 in mouse one-cell stage embryos.

Authors:  Zhe Zhang; Guojun Zhang; Xiaoyan Xu; Wenhui Su; Bingzhi Yu
Journal:  Mol Cell Biochem       Date:  2011-11-05       Impact factor: 3.396

8.  mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.

Authors:  Louis-Andre Julien; Audrey Carriere; Julie Moreau; Philippe P Roux
Journal:  Mol Cell Biol       Date:  2009-12-07       Impact factor: 4.272

Review 9.  mTOR signaling: at the crossroads of plasticity, memory and disease.

Authors:  Charles A Hoeffer; Eric Klann
Journal:  Trends Neurosci       Date:  2009-12-04       Impact factor: 13.837

Review 10.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.